Cerebrolysin Dosage Guide
Complete guide to Cerebrolysin dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
2150 mg – 4300 mg
Frequency
Once per day
Route
intramuscular
Cycle Length
1–2 weeks
Reconstitution
Vial Size
215 mg
BAC Water
1.0 ml
Concentration
215,000 mcg/ml
Detailed Dosage Information
Clinical dosing
10-30ml IV daily for acute conditions.
Research use
5-10ml IM daily for cognitive enhancement.
Treatment courses typically last 10-20 days.
Administration Method
Administered via intramuscular or intravenous injection. IV administration is typically used in clinical settings. IM can be used for research purposes.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 215 mg/ml
Volume to inject: 15.000 ml
Syringe units: 1500.0 units — exceeds 1 ml syringe, split into multiple injections
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with Cerebrolysin defaults. Adjust values as needed.
Side Effects to Monitor
Generally well-tolerated. May cause dizziness, headache, sweating, or injection site reactions. Rare cases of agitation or confusion.
Safety Considerations & Risks
Not FDA-approved in the US. Should be avoided in severe renal impairment and epilepsy. Quality and sourcing concerns outside clinical settings.